Winston Laboratories, Inc. Submits NDA for CIVANEX(R) (Civamide Cream) for ... - MarketWatch (press release)

Winston Laboratories, Inc. Submits NDA for CIVANEX(R) (Civamide Cream) for ... MarketWatch (press release) Osteoarthritis is the most common form of arthritis, affecting more than 21 million Americans, mainly adults over age 45. Women are more susceptible to this ... and more »

EC Clears BMS' Orencia for Earlier Use in Treating RA - Genetic Engineering News

Genetic Engineering News

EC Clears BMS' Orencia for Earlier Use in Treating RA Genetic Engineering News The agency sanctioned the therapy for reducing the signs and symptoms of RA, inducing major clinical response, slowing the progression of structural damage, ... and more »

Arthritis increases chances of heart attacks - IBNLive.com

Arthritis increases chances of heart attacks IBNLive.com This is what could be waiting to happen to 80% of the 10 million Indians with rheumatoid arthritis. So if you develop symptoms like joint pains and ... Routine Vaccinations Do Not Increase Rheumatoid Arthritis RiskMedical News Today (press release) all 10 news articles »

Glucosamine Shows No Benefit for Back Pain Patients in Study - BusinessWeek

TopNews United Kingdom (blog)

Glucosamine Shows No Benefit for Back Pain Patients in Study BusinessWeek ... on the condition over 16 weeks, though it did relieve some symptoms. A 2008 trial found the supplement failed to help patients with hip arthritis. ... Beliefs and Behaviors Influence Back Pain DisabilityMedPage Today Glucosamine No Better Than Placebo for Lower Back Pain Caused by ArthritiseMaxHealth all 84 news articles »